Skip to main content
. 2020 Oct 27;38(36):4249–4259. doi: 10.1200/JCO.19.03277

FIG 1.

FIG 1.

Flowchart of the study participants. (*) Observation was stopped according to the visit schedule, and only disease status and survival of the patients were followed. cGVHD, chronic graft-versus-host disease; Dec, decitabine; rhG-CSF, recombinant human granulocyte colony-stimulating factor.